High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to avapritinib, a drug already approved by the US FDA. The corresponding study was published in Cancer…
High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to avapritinib, a drug already approved by the US FDA. The corresponding study was published in Cancer…